A five-year evaluation of intervention in diabetes care in Trinidad and Tobago

Diabetic Medicine

Volumn 16, Issue 11, 1999, Pages 939-945

  Gulliford, M C ^a   Mahabir, D ^b  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b NONE

Author keywords

Guidelines; Medical audit; Primary care; Quality of care

Indexed keywords

ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BRISERIN; CALCIUM CHANNEL BLOCKING AGENT; CHLORPROPAMIDE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLIBENCLAMIDE; GLICLAZIDE; INSULIN; METFORMIN; METHYLDOPA; THIAZIDE DIURETIC AGENT;

ADULT; AGED; ARTICLE; BLOOD GLUCOSE MONITORING; BLOOD PRESSURE REGULATION; BODY WEIGHT; DIABETES MELLITUS; DIABETIC DIET; FEMALE; HEALTH CARE QUALITY; HUMAN; MAJOR CLINICAL STUDY; MALE; PRACTICE GUIDELINE; PREVALENCE; TRINIDAD AND TOBAGO;

ANTIHYPERTENSIVE AGENTS; COMMUNITY HEALTH CENTERS; CROSS-SECTIONAL STUDIES; DELIVERY OF HEALTH CARE; DIABETES MELLITUS; DIABETIC ANGIOPATHIES; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; PRIMARY HEALTH CARE; QUALITY ASSURANCE, HEALTH CARE; QUESTIONNAIRES; TRINIDAD AND TOBAGO;

EID: 0032704145     PISSN: 07423071     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1464-5491.1999.00154.x     Document Type: Article

References (25)

1. Amos AF, McCarty DJ, Zimmet P. The rising global burden of diabetes and its complications: estimates and projections to the year 2010. Diabet Med 1997; 14: S1-S85.
2. Miller GJ, Beckles GLA, Maude GH, Carson DC, Alexis SD, Price SG et al. Ethnicity and other characteristics predictive of coronary heart disease in a developing community: principal results of the St James survey, Trinidad. Int J Epidemiol 1989; 18: 808-817.
3. Ragoobirsingh D, Lewis-Fuller E, Morrison EYStA. The Jamaican Diabetes Survey. A protocol for the Caribbean. Diabetes Care 1995; 18: 1277-1279.
4. Gulliford MC. Epidemiological transition in Trinidad and Tobago, West Indies 1953-92. Int J Epidemiol 1996; 25: 357-365.
5. Gulliford MC, Ariyanayagam-Baksh SM, Bickram L, Picou D, Mahabir D. Counting the cost of diabetic hospital admissions from a multi-ethnic population in Trinidad and Tobago. Diabet Med 1995; 12: 1077-1085.
6. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998; 352: 837-853.
7. UK Prospective Diabetes Study (UKPDS) Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. Br Med J 1998; 317: 703-713.
8. Williams DRR, Munroe C, Hospedales CJ, Greenwood RH. A three year evaluation of the quality of care in the Norwich community care scheme. Diabet Med 1990; 7: 74-79.
9. Gulliford MC, Alert CV, Mahabir D, Ariyanayagam-Baksh SM, Fraser HS, Picou D. Diabetes care in middle income countries: a Caribbean case study. Diabet Med 1996; 13: 574-581.
10. Commonwealth Caribbean Medical Research Council. Managing Diabetes in Primary Care. Port of Spain: CCMRC, 1995.
11. Report of a Joint Working Party of the British Diabetic Association and the Research Unit of the Royal College of Physicians and the Royal College of General Practitioners. Guidelines for good practice in the diagnosis and treatment of non-insulin-dependent diabetes mellitus. J Roy Coll Phys Lond 1993; 27: 259-266.
12. Stata Corporation. Stata Statistical Software Release 5. College Station, Texas: Stata Press, 1997: 596-615.
13. Cook TD, Campbell DT. Quasi-Experimentation Design and Analysis Issues for Field Settings. Chicago: Rand McNally College Publishing Company, 1979.
14. Dowse GK, Gareebo H, Alberti KG, Zimmet P, Tuomilehto J, Purran A et al. Changes in population cholesterol concentrations and other cardiovascular risk factor levels after five years of the non-communicable disease intervention programme in Mauritius. Br Med J 1995; 311: 1208-1212.
15. Grimshaw JM, Russell TT. Effect of Clinical Guidelines on Medical Practice: a Systematic Review of Rigorous Evaluations. Lancet 1993; 342: 1317-1322.
16. UK Prospective Diabetes Study (UKPDS) Group. Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 39. Br Med J 1998; 317: 713-720.
17. Mant J, Hicks N. Detecting differences in quality of care: the sensitivity of measures of process and outcome in treating acute myocardial infarction. Br Med J 1995; 311: 793-796.
18. Dunn N, Pickering R. Does good practice organisation improve the outcome of care for diabetic patients? Br J Gen Pract 1998; 48: 1237-1240.
19. Diehr P, Martin DC, Koepsell T, Cheadle A, Psaty BM, Wagner EH. Optimal survey design for community intervention evaluations: cohort or cross-sectional? J Clin Epidemiol 1995; 48: 1461-1472.
20. Feldman HA, McKinlay, SM. Cohort versus cross-sectional design in large field trials: precision, sample size and unifying model. Statist Med 1994; 13: 61-78.
21. Vaughan JP, Gilson L, Mills A. Diabetes. In Jamison DT, Mosley WH, Measham AR, Bobadilla JL eds. Disease control priorities in developing countries. New York: Oxford University Press, 1993: 561-576.
22. Gagliardino JJ, Olivera EM, Barragan H, Puppo RA. A simple economic evaluation model for selecting diabetes health care strategies. Diabetic Med 1993; 10: 351-354.
23. Eastman RC, Javitt JC, Herman WH, Dasbach EJ, Copley-Merriman C, Maier W et al. Model of complications of NIDDM. II. Analysis of the health benefits and cost-effectiveness of treating NIDDM with the goal of normoglycemia. Diabetes Care 1997; 20: 735-44.
24. Gulliford MC. Design of cost-effective packages of care for non-insulin-dependent diabetes mellitus. Int J Technol Assess Health Care 1997; 13: 395-410.
25. Oxman AD, Thomson MA, Davis DA, Haynes RB. No magic bullets: a systematic review of 102 trials of interventions to improve professional practice. CMAJ 1995; 153: 1423-1431.